Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung.
Yu GuHongcheng ZhuJiaying DengJunhua ZhangTianxiang ChenSongtao LaiPublished in: Cancer medicine (2023)
The prognosis of patients with resectable III-N2 primary lung PMA was significantly worse than that of other ADCs, and PORT was an independent prognostic factor. Patients with ≤7 positive lymph nodes could benefit from PORT and those with >7 positive lymph nodes could benefit from chemotherapy.